Morbidity and Mortality of Laparoscopic Versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Trial
Authors:
- Yanfeng HuYHYanfeng Hu
- Changming HuangCHChangming Huang
- Yihong SunYSYihong Sun
- Xiangqian SuXSXiangqian Su
- Hui CaoHCHui Cao
- Jiankun HuJHJiankun Hu
- Yingwei XueYXYingwei Xue
- Jian SuoJSJian Suo
- Kaixiong TaoKTKaixiong Tao
- Xianli HeXHXianli He
- Hongbo WeiHWHongbo Wei
- Mingang YingMYMingang Ying
Top Cited Papers
- 20 April 2016
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 34 (12) , 1350-1357
Abstract
Purpose The safety and efficacy of radical laparoscopic distal gastrectomy (LG) with D2 lymphadenectomy for the treatment of advanced gastric cancer (AGC) remain controversial. We conducted a randomized controlled trial to compare laparoscopic and conventional open distal gastrectomy with D2 lymph node dissections for AGC. Patients and Methods Between September 2012 and December 2014, 1,056 patients with clinical stage T2-4aN0-3M0 gastric cancer were eligible for inclusion. They were randomly assigned to either the LG with D2 lymphadenectomy group (n = 528) or the open gastrectomy (OG) with D2 lymphadenectomy group (n = 528). Fifteen experienced surgeons from 14 institutions in China participated in the study. The morbidity and mortality within 30 days after surgery between the LG (n = 519) and the OG (n = 520) groups were compared on the basis of the modified intention-to-treat principle. Postoperative complications were stratified according to the Clavien-Dindo classification. Results The compliance rates of D2 lymphadenectomy were similar between the LG and OG groups (99.4% v 99.6%; P = .845). The postoperative morbidity was 15.2% in the LG group and 12.9% in OG group with no significant difference (difference, 2.3%; 95% CI, –1.9 to 6.6; P = .285). The mortality rate was 0.4% for the LG group and zero for the OG group (difference, 0.4%; 95% CI, –0.4 to 1.4; P = .249). The distribution of severity was similar between the two groups (P = .314). Conclusion Experienced surgeons can safely perform LG with D2 lymphadenectomy for AGC.Keywords
This publication has 29 references indexed in Scilit:
- Long-Term Results of Laparoscopic Gastrectomy for Gastric Cancer: A Large-Scale Case-Control and Case-Matched Korean Multicenter StudyJournal of Clinical Oncology, 2014
- Japanese gastric cancer treatment guidelines 2010 (ver. 3)Gastric Cancer, 2011
- A new order of D2 lymphadenectomy in laparoscopic gastrectomy for cancer: Live anatomy-based dissectionMinimally Invasive Therapy & Allied Technologies, 2010
- Safety and feasibility of laparoscopy-assisted distal gastrectomy with suprapancreatic nodal dissection for clinical stage I gastric cancer: a multicenter phase II trial (JCOG 0703)Gastric Cancer, 2010
- Morbidity and Mortality of Laparoscopic Gastrectomy Versus Open Gastrectomy for Gastric CancerAnnals of Surgery, 2010
- Long‐term outcomes after laparoscopy‐assisted gastrectomy for advanced gastric cancer: Analysis of consecutive 106 experiencesJournal of Surgical Oncology, 2009
- Laparoscopic Versus Open Subtotal Gastrectomy for Distal Gastric CancerAnnals of Surgery, 2005
- A randomized controlled trial comparing open vs laparoscopy-assisted distal gastrectomy for the treatment of early gastric cancer: An interim reportSurgery, 2002
- Early Experience With Laparoscopic Radical Gastrectomy for Advanced Gastric CancerSurgical Laparoscopy, Endoscopy & Percutaneous Techniques, 2001
- Laparoscopic total gastrectomy with distal pancreatosplenectomy and D2 lymphadenectomy for advanced gastric cancerGastric Cancer, 1999